data_1mea_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1mea _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.1 t -103.32 124.63 49.03 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 111.329 -2.436 . . . . 0.0 105.927 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -131.24 36.24 3.83 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 113.852 -1.522 . . . . 0.0 111.146 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -40.77 -60.69 1.1 Allowed 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 101.856 -3.387 . . . . 0.0 101.856 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.741 ' CE1' ' HA ' ' A' ' 10' ' ' CYS . 0.6 OUTLIER -139.92 166.23 25.2 Favored 'General case' 0 C--N 1.303 -1.43 2 N-CA-C 93.482 -6.488 . . . . 0.0 93.482 179.601 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.472 ' H ' ' HD1' ' A' ' 5' ' ' PHE 0.319 24.7 t -100.42 100.14 9.82 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 CA-C-N 113.224 -1.807 . . . . 0.0 108.076 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt 75.92 57.95 0.05 Allowed 'General case' 0 N--CA 1.506 2.341 0 C-N-CA 125.618 1.567 . . . . 0.0 113.271 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.473 ' HA3' ' CE1' ' A' ' 19' ' ' TYR . . . 40.0 -2.17 0.0 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 121.757 3.463 . . . . 0.0 121.757 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 10' ' ' CYS . 25.1 m -137.55 178.17 7.3 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.741 ' HA ' ' CE1' ' A' ' 5' ' ' PHE . 42.1 t -86.15 96.68 0.51 Allowed Pre-proline 0 C--N 1.309 -1.172 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -63.14 -15.3 47.18 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.064 1.843 . . . . 0.0 109.532 -143.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -88.29 -50.99 6.0 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 113.412 -1.722 . . . . 0.0 111.682 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.594 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 16.8 p -105.25 11.22 33.22 Favored 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 123.178 1.466 . . . . 0.0 113.197 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . 0.344 9.1 tttp -2.05 87.47 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 109.505 -3.498 . . . . 0.0 118.966 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.4 t -89.47 103.09 5.28 Favored Pre-proline 0 N--CA 1.489 1.499 0 CA-C-N 109.373 -3.558 . . . . 0.0 103.876 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -14.74 -51.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 1 C-N-CA 125.961 4.441 . . . . 0.0 121.563 -143.277 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -134.35 85.14 2.16 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.509 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 5.3 mm100 -94.69 76.67 3.72 Favored 'General case' 0 N--CA 1.505 2.307 0 CA-C-O 123.08 1.419 . . . . 0.0 110.922 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.473 ' CE1' ' HA3' ' A' ' 8' ' ' GLY . 91.1 m-85 -99.78 -54.62 2.87 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 101.025 -3.694 . . . . 0.0 101.025 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.44 30.67 4.43 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.509 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 24.4 m-20 -122.07 36.28 4.67 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 123.76 0.329 . . . . 0.0 110.794 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -5.79 77.79 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 O-C-N 125.483 1.739 . . . . 0.0 114.148 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.444 ' HA ' HE21 ' A' ' 18' ' ' GLN . 37.6 t 5.82 96.8 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 117.64 2.459 . . . . 0.0 117.64 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -101.33 39.45 1.42 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.561 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.594 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 21.5 t -119.48 -55.78 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.582 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 28.7 p -114.36 -43.55 3.19 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 124.08 0.862 . . . . 0.0 109.858 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.06 67.33 0.24 Allowed Glycine 0 N--CA 1.501 2.997 0 C-N-CA 120.297 -0.954 . . . . 0.0 114.933 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 2.459 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 179.871 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.1 t -103.32 124.63 49.03 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 111.329 -2.436 . . . . 0.0 105.927 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -131.24 36.24 3.83 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 113.852 -1.522 . . . . 0.0 111.146 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -40.77 -60.69 1.1 Allowed 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 101.856 -3.387 . . . . 0.0 101.856 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.805 ' CE1' ' HA ' ' A' ' 10' ' ' CYS . 0.6 OUTLIER -139.92 166.23 25.2 Favored 'General case' 0 C--N 1.303 -1.43 2 N-CA-C 93.482 -6.488 . . . . 0.0 93.482 179.601 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.536 ' H ' ' HD1' ' A' ' 5' ' ' PHE 0.319 24.7 t -100.42 100.14 9.82 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 CA-C-N 113.224 -1.807 . . . . 0.0 108.076 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt 75.92 57.95 0.05 Allowed 'General case' 0 N--CA 1.506 2.341 0 C-N-CA 125.618 1.567 . . . . 0.0 113.271 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.511 ' HA3' ' CE1' ' A' ' 19' ' ' TYR . . . 40.0 -2.17 0.0 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 121.757 3.463 . . . . 0.0 121.757 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.523 HG22 ' HA ' ' A' ' 14' ' ' LYS . 25.1 m -137.55 178.17 7.3 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.805 ' HA ' ' CE1' ' A' ' 5' ' ' PHE . 42.1 t -86.15 96.68 0.51 Allowed Pre-proline 0 C--N 1.309 -1.172 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -63.14 -15.3 47.18 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.064 1.843 . . . . 0.0 109.532 -143.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -88.29 -50.99 6.0 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 113.412 -1.722 . . . . 0.0 111.682 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.603 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 16.8 p -105.25 11.22 33.22 Favored 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 123.178 1.466 . . . . 0.0 113.197 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.523 ' HA ' HG22 ' A' ' 9' ' ' THR 0.344 9.1 tttp -2.05 87.47 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 109.505 -3.498 . . . . 0.0 118.966 178.67 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.4 t -89.47 103.09 5.28 Favored Pre-proline 0 N--CA 1.489 1.499 0 CA-C-N 109.373 -3.558 . . . . 0.0 103.876 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -14.74 -51.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 1 C-N-CA 125.961 4.441 . . . . 0.0 121.563 -143.277 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.403 ' HB2' ' CE2' ' A' ' 19' ' ' TYR . 5.9 p-10 -134.35 85.14 2.16 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.564 HE21 ' HA ' ' A' ' 23' ' ' CYS . 5.3 mm100 -94.69 76.67 3.72 Favored 'General case' 0 N--CA 1.505 2.307 0 CA-C-O 123.08 1.419 . . . . 0.0 110.922 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.511 ' CE1' ' HA3' ' A' ' 8' ' ' GLY . 91.1 m-85 -99.78 -54.62 2.87 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 101.025 -3.694 . . . . 0.0 101.025 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.44 30.67 4.43 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.55 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 24.4 m-20 -122.07 36.28 4.67 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 123.76 0.329 . . . . 0.0 110.794 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -5.79 77.79 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 O-C-N 125.483 1.739 . . . . 0.0 114.148 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.564 ' HA ' HE21 ' A' ' 18' ' ' GLN . 37.6 t 5.82 96.8 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 117.64 2.459 . . . . 0.0 117.64 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -101.33 39.45 1.42 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.561 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.603 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 21.5 t -119.48 -55.78 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.582 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 28.7 p -114.36 -43.55 3.19 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 124.08 0.862 . . . . 0.0 109.858 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.06 67.33 0.24 Allowed Glycine 0 N--CA 1.501 2.997 0 C-N-CA 120.297 -0.954 . . . . 0.0 114.933 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 2.459 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 179.871 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.1 t -103.32 124.63 49.03 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 111.329 -2.436 . . . . 0.0 105.927 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -131.24 36.24 3.83 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 113.852 -1.522 . . . . 0.0 111.146 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -40.77 -60.69 1.1 Allowed 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 101.856 -3.387 . . . . 0.0 101.856 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.805 ' CE1' ' HA ' ' A' ' 10' ' ' CYS . 0.6 OUTLIER -139.92 166.23 25.2 Favored 'General case' 0 C--N 1.303 -1.43 2 N-CA-C 93.482 -6.488 . . . . 0.0 93.482 179.601 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.536 ' H ' ' HD1' ' A' ' 5' ' ' PHE 0.319 24.7 t -100.42 100.14 9.82 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 CA-C-N 113.224 -1.807 . . . . 0.0 108.076 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt 75.92 57.95 0.05 Allowed 'General case' 0 N--CA 1.506 2.341 0 C-N-CA 125.618 1.567 . . . . 0.0 113.271 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.511 ' HA3' ' CE1' ' A' ' 19' ' ' TYR . . . 40.0 -2.17 0.0 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 121.757 3.463 . . . . 0.0 121.757 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.523 HG22 ' HA ' ' A' ' 14' ' ' LYS . 25.1 m -137.55 178.17 7.3 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.805 ' HA ' ' CE1' ' A' ' 5' ' ' PHE . 42.1 t -86.15 96.68 0.51 Allowed Pre-proline 0 C--N 1.309 -1.172 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -63.14 -15.3 47.18 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.064 1.843 . . . . 0.0 109.532 -143.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -88.29 -50.99 6.0 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 113.412 -1.722 . . . . 0.0 111.682 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.603 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 16.8 p -105.25 11.22 33.22 Favored 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 123.178 1.466 . . . . 0.0 113.197 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.523 ' HA ' HG22 ' A' ' 9' ' ' THR 0.344 9.1 tttp -2.05 87.47 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 109.505 -3.498 . . . . 0.0 118.966 178.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.4 t -89.47 103.09 5.28 Favored Pre-proline 0 N--CA 1.489 1.499 0 CA-C-N 109.373 -3.558 . . . . 0.0 103.876 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -14.74 -51.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 1 C-N-CA 125.961 4.441 . . . . 0.0 121.563 -143.277 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.403 ' HB2' ' CE2' ' A' ' 19' ' ' TYR . 5.9 p-10 -134.35 85.14 2.16 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.564 HE21 ' HA ' ' A' ' 23' ' ' CYS . 5.3 mm100 -94.69 76.67 3.72 Favored 'General case' 0 N--CA 1.505 2.307 0 CA-C-O 123.08 1.419 . . . . 0.0 110.922 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.511 ' CE1' ' HA3' ' A' ' 8' ' ' GLY . 91.1 m-85 -99.78 -54.62 2.87 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 101.025 -3.694 . . . . 0.0 101.025 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.44 30.67 4.43 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.55 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 24.4 m-20 -122.07 36.28 4.67 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 123.76 0.329 . . . . 0.0 110.794 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -5.79 77.79 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 O-C-N 125.483 1.739 . . . . 0.0 114.148 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.564 ' HA ' HE21 ' A' ' 18' ' ' GLN . 37.6 t 5.82 96.8 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 117.64 2.459 . . . . 0.0 117.64 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -101.33 39.45 1.42 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.561 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.603 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 21.5 t -119.48 -55.78 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.582 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 28.7 p -114.36 -43.55 3.19 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 124.08 0.862 . . . . 0.0 109.858 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.06 67.33 0.24 Allowed Glycine 0 N--CA 1.501 2.997 0 C-N-CA 120.297 -0.954 . . . . 0.0 114.933 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 2.459 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 179.871 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_